← FDA DRUG APPROVALS

FDA ANDA · ANDA217914

LACTULOSE

Sponsor: PAI HOLDINGS

APPLICATION
ANDA217914
TYPE
ANDA
ORIGINAL APPROVAL
2025-03-14
LATEST ACTION
2025-03-14
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Prescription

Products

LACTULOSEPrescription
LACTULOSE 10GM/PACKET · FOR SOLUTION · ORAL
LACTULOSEPrescription
LACTULOSE 20GM/PACKET · FOR SOLUTION · ORAL

Approval history

2025-03-14UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →